metronomic chemotherapy
Metronomic chemotherapy: changing the paradigm that more is better
9
The Immune Response and the Therapeutic Effect of Metronomic Chemotherapy With Cyclophosphamide
6
Therapeutic efficacy of metronomic chemotherapy with cyclophosphamide and doxorubicin on murine mammary adenocarcinomas
24
Safety and therapeutic effect of metronomic chemotherapy with cyclophosphamide and celecoxib in advanced breast cancer patients
27
Comparative Effectiveness of Two Metronomic Chemotherapy Schedules Our Experience in the Preclinical Field
17
Metastatic breast cancer patients treated with low dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response
25
Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
10
Association between baseline VEGF/sVEGFR 2 and VEGF/TSP 1 ratios and response to metronomic chemotherapy using cyclophosphamide and celecoxib in patients with advanced breast cancer
7
Lessons from the Fourth Metronomic and Anti angiogenic Therapy Meeting, 24–25 June 2014, Milan
18
Metronomic therapy with cyclophosphamide induces rat lymphoma and sarcoma regression, and is devoid of toxicity
8
Cholestatic hepatitis C after chemotherapy containing rituximab in diffuse large B cell lymphoma
6
Globe salvage with intra arterial topotecan melphalan chemotherapy in children with a single eye
6
Askin tumor: Case report and literature review
5
Eficacia de la radioterapia y la quimioterapia combinadas comparada con la radioterapia en el carcinoma oral de clulas escamosas
7
Melatonin induced oncostasis, mechanisms and clinical relevance
25
Patterns of bacterial resistance in urinary isolates at a public health care center
7
Thymosin β10 as a predictive biomarker of response to 5 fluorouracil chemotherapy in cholangiocarcinoma
9
Test de seguridad y efectividad en el control de fluidos y distribución del fármaco durante el desarrollo de un modelo de acceso laparoscópico para cirugía citorreductora y uso de paclitaxel en cavidad abdominal hipertérmica mediante un sistema cerrado con recirculación de CO2 en un modelo experimental porcino
304
Circulating Tumor Cells Following First Chemotherapy Cycle: An Early and Strong Predictor of Outcome in Patients With Metastatic Breast Cancer
7
Efecto del immunepotent CRP en la respuesta clínica e inmunológica en pacientes con cáncer de mama.
82